data_1zfu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zfu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.953 0.406 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.34 51.72 0.49 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -176.04 99.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 0.0 110.781 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.58 -49.2 16.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.29 -141.48 8.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' CE1' ' A' ' 35' ' ' PHE . 45.9 Cg_endo -68.57 -46.95 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.635 2.223 . . . . 0.0 112.521 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 45.0 p90 -57.71 -40.42 79.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -153.78 151.88 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -175.27 157.6 2.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -145.63 145.47 30.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.741 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.82 -46.83 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.05 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -51.82 66.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.2 t -75.77 -30.83 59.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.02 -39.47 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.946 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -59.78 -51.18 70.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -59.6 -31.09 69.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -75.29 -30.48 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.3 m -58.99 -31.14 68.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 25' ' ' TYR . 23.2 mt -85.56 139.98 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 142.68 36.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.33 13.79 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 21.3 m-85 -76.29 -178.31 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 -58.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.25 -169.79 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.19 172.56 27.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -164.1 145.3 8.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.824 0.345 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.0 m -69.99 122.06 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.81 165.71 11.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 60.9 70.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 56.26 36.25 68.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.641 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.49 52.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.441 ' CE1' ' CD ' ' A' ' 7' ' ' PRO . 85.6 m-85 -100.09 -25.55 14.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.15 159.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.19 138.76 54.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -142.95 154.32 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 79.8 m -116.99 156.1 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.965 0.412 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 19.1 43.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.937 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.59 100.05 10.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 0.0 110.755 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -99.63 29.91 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.9 -150.69 46.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.64 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.97 -20.86 46.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.57 -64.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.958 0.408 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -152.69 148.07 26.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.734 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.67 149.78 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.33 178.52 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.22 -28.44 12.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.3 mtp -99.55 -24.77 14.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.44 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -62.94 1.31 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -59.36 -31.58 69.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.405 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 13.5 t60 -68.29 -26.79 65.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -70.44 -51.02 32.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.238 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -49.96 -63.47 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 m -54.19 -26.15 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -29.0 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -97.16 37.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 22' ' ' ILE . 31.6 mt -137.92 152.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -64.72 128.35 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.173 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -58.02 5.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.761 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 5.1 m-30 -53.53 169.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 111.294 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 -55.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . -163.3 -88.41 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.24 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.0 -152.15 24.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.634 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -150.44 -177.6 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.98 157.64 18.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.25 158.8 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 62.28 70.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.42 69.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.642 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.14 31.01 77.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.539 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -32.57 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.948 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.2 152.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.195 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 118.32 31.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.9 161.0 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 25' ' ' TYR . 74.4 m -138.0 151.55 48.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.775 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.914 0.388 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.04 -28.57 3.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.41 124.18 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.64 77.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.54 160.34 29.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.608 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD2' ' CE3' ' A' ' 8' ' ' TRP . 22.5 Cg_exo -64.57 -40.59 22.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.424 ' CE3' ' HD2' ' A' ' 7' ' ' PRO . 25.0 p90 -62.44 -47.08 85.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.265 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -116.9 125.22 51.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -161.78 175.92 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.89 132.33 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -49.19 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -37.59 77.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -59.68 -53.83 53.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -23.59 59.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.021 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -46.06 80.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.009 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -58.42 -41.16 84.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -64.2 -48.86 74.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.56 -44.36 90.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -58.49 -23.25 57.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.03 38.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 25' ' ' TYR . 53.6 mt -146.59 103.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tttm 50.38 31.22 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.5 -82.55 1.38 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 21.9 m-30 55.41 -177.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.866 0.365 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -128.25 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.62 -143.82 16.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.78 -176.75 47.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -138.75 157.95 45.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 m -82.06 111.2 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.96 151.68 21.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 30.33 12.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.007 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.91 -21.89 34.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.65 -19.11 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.659 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.61 -25.6 27.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 0.0 111.125 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.25 116.54 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 104.85 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.66 173.18 7.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.0 m -131.57 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.92 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.899 0.381 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.57 84.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 109.35 21.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -97.54 36.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.19 -145.58 49.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.39 -8.66 23.81 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 0.0 112.621 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -66.87 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.16 100.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.13 159.36 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.47 150.19 30.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.19 -26.48 13.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 ttm -94.12 -33.29 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -45.74 89.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.0 t -82.03 -36.96 27.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.8 -53.67 50.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -57.92 -30.88 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -65.24 -41.2 94.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.2 m -70.55 -41.06 72.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -26.31 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -91.71 47.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 25' ' ' TYR . 31.8 mt -142.89 156.83 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.077 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -79.84 106.8 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.57 10.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.546 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 22' ' ' ILE . 6.5 m-85 -128.21 151.46 49.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 -42.42 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.47 -165.34 33.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 165.19 -158.46 31.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.554 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.86 -165.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.324 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 163.33 13.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.039 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.61 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 61.12 32.36 19.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.06 -19.28 54.05 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.19 0.91 5.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.093 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -87.15 0.04 55.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 111.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.62 110.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.25 24.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.705 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -106.92 178.41 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m -149.71 165.36 32.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.438 ' CE2' ' HA2' ' A' ' 28' ' ' GLY . 35.2 p90 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.6 m-30 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.97 2.04 5.12 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.805 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 100.02 10.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -61.49 -59.48 5.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.48 -169.26 42.39 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.454 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.11 -30.02 68.61 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.518 2.146 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -74.08 -48.61 28.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.041 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.76 143.36 47.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.6 159.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -135.38 134.2 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.622 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.13 -45.42 73.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -10.1 59.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.455 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -59.25 -59.07 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 111.088 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.9 m -59.41 -43.84 92.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.857 0.36 . . . . 0.0 110.784 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -50.83 -27.17 6.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.326 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -59.24 -52.85 63.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -79.91 -33.2 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.4 m -54.82 -34.1 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -31.15 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -62.29 -18.27 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HB ' ' CG ' ' A' ' 25' ' ' TYR . 1.6 mm -77.26 167.12 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -97.29 119.16 35.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.84 18.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.601 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.427 ' CG ' ' HB ' ' A' ' 22' ' ' ILE . 4.1 m-30 -58.63 177.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 31.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.11 -176.6 48.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.23 -135.99 2.27 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -170.78 173.62 5.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 m -70.51 152.96 43.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.75 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.59 35.42 20.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.974 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.12 -1.61 86.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.883 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 18.62 6.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.709 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.21 -27.73 13.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.04 155.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.6 m -110.01 132.39 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.517 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -108.53 149.66 28.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.049 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 9.8 m -146.11 152.93 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.947 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.68 0.276 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.98 -34.57 2.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 109.49 21.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -84.78 -41.4 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.29 -150.83 22.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.601 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.24 -13.58 36.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.776 2.317 . . . . 0.0 112.787 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -29.28 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.268 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -159.74 148.27 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -176.96 118.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.4 158.42 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -98.77 -30.68 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -30.49 29.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -58.14 -31.93 67.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.7 m -91.42 -35.36 14.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -64.09 -47.3 80.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -56.58 -27.71 58.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.54 -24.75 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.2 t -77.07 -71.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -23.28 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -31.39 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.7 mt -75.83 158.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.074 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -88.56 85.0 6.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.93 -28.15 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.21 172.03 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -129.91 -56.27 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.787 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 167.09 40.19 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.267 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.76 -163.27 9.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.66 177.06 10.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.41 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 32.8 m -96.13 105.67 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.15 179.93 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.0 33.61 9.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.36 81.28 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.975 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 120.44 9.97 7.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -100.09 -33.23 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 111.041 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.4 t -100.84 154.39 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.439 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 89.84 2.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.07 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.295 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.9 m -138.43 -174.2 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.775 0.322 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.22 -25.96 20.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.594 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 99.97 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.583 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.77 -48.51 12.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.78 -156.17 24.41 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.51 -36.88 3.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.605 2.203 . . . . 0.0 112.42 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.23 -29.45 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -156.14 140.55 16.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.18 162.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.003 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -118.1 142.85 46.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -100.1 -29.79 12.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -33.21 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -59.48 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -23.06 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.411 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 79.9 t60 -81.6 -40.53 22.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.066 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.74 -58.75 6.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -55.33 -40.83 71.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -58.81 -41.88 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -43.13 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -22.54 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 22' ' ' ILE . 29.3 mt -63.98 162.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.29 89.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 44.11 27.11 1.02 Allowed Glycine 0 CA--C 1.521 0.424 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.039 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.471 ' CG ' ' HB ' ' A' ' 22' ' ' ILE . 3.4 m-30 -57.09 159.13 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.141 0.471 . . . . 0.0 110.599 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -103.08 36.41 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . 70.85 152.8 1.0 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.16 -169.02 14.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.44 166.32 6.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 130.18 41.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.0 174.15 8.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.089 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.15 35.26 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.66 -20.61 48.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.63 8.0 5.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.045 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 0.23 40.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.8 0.3 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.99 157.79 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 111.268 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 105.3 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -107.57 152.01 24.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 19.9 m -123.24 -175.97 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.996 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 2.1 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.882 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.42 -34.95 2.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 100.06 10.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -109.63 92.05 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.28 152.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.567 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.87 -26.03 23.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.616 2.211 . . . . 0.0 112.4 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.406 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 12.5 p90 -69.18 -34.06 74.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.026 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 6.1 m-20 -132.55 123.76 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.74 144.81 20.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.99 148.47 50.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -100.07 -44.92 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mmt -74.83 -35.22 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.57 -34.73 69.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.15 -27.89 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -75.17 -47.76 26.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -65.7 -42.02 91.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.38 -49.7 76.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.092 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.9 m -59.21 -40.85 87.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.28 -28.35 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -10.42 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 25' ' ' TYR . 7.5 mt -89.13 165.08 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.657 0.265 . . . . 0.0 111.025 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -41.2 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 43.49 73.02 0.27 Allowed Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.079 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.47 ' CD1' ' HB ' ' A' ' 22' ' ' ILE . 3.2 m-85 -103.71 163.74 12.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 12.3 mttm -122.24 43.51 2.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -171.46 30.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.29 -141.32 3.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.86 -166.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.0 m -101.98 117.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.38 153.58 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.051 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? 58.6 37.53 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.23 -81.55 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.91 26.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.536 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -100.15 -38.45 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.57 159.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 112.9 9.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -114.35 154.57 27.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -170.35 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.721 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CZ ' ' O ' ' A' ' 26' ' ' LYS . 6.1 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.848 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.99 -26.5 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -99.96 99.98 10.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.82 0.343 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -89.8 -38.31 13.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.409 ' HA2' ' CD1' ' A' ' 35' ' ' PHE . . . -165.29 169.63 39.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.522 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HD2' ' CZ3' ' A' ' 8' ' ' TRP . 60.1 Cg_exo -51.66 -33.68 50.16 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CZ3' ' HD2' ' A' ' 7' ' ' PRO . 45.9 p90 -87.9 -33.75 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.17 111.02 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -157.58 173.73 16.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.024 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 159.53 38.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -100.21 -38.8 8.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.9 mmt -99.67 -29.57 12.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.376 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.41 -34.57 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.03 -29.33 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.41 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 33.5 t60 -73.74 -46.32 46.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.975 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.36 -45.93 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -63.25 -47.76 81.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.18 -30.15 71.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -32.57 68.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -28.26 65.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.078 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.33 157.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.29 147.48 25.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.69 -35.61 4.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.575 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -102.21 165.31 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -119.05 31.06 6.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . 138.71 -159.1 25.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.67 167.84 39.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.7 161.64 13.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 82.2 m -86.34 109.91 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' VAL . . . -89.9 -178.68 5.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.973 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.6 mttp 49.76 69.1 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.44 54.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.173 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 74.31 16.1 79.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.409 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 1.8 t80 -100.29 0.21 39.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' ALA . 87.7 t -142.02 114.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.703 0.287 . . . . 0.0 111.446 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.82 138.84 31.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.629 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 178.46 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.409 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -118.22 120.86 38.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.875 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.89 28.65 11.84 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 108.15 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.747 0.308 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HB3' ' CH2' ' A' ' 8' ' ' TRP . 18.6 m-80 -124.46 39.86 3.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.23 -149.91 38.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.57 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -72.89 -41.8 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.673 2.249 . . . . 0.0 112.529 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -57.83 -28.62 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -159.46 136.51 9.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.909 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -178.15 138.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.03 161.39 26.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -100.09 -33.66 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.228 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.13 -26.61 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.265 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -58.71 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.021 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.41 -30.12 71.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.432 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 13.4 t60 -57.7 -44.4 85.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.83 -45.6 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.07 -59.71 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.7 t -71.48 -10.03 59.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.591 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -42.46 63.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 110.655 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 57.87 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 mt -144.37 141.84 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.0 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.39 128.12 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -63.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.615 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 1.5 m-85 -62.65 142.81 57.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 -33.64 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . -142.04 -134.7 3.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.11 156.5 14.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -155.36 -173.59 4.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.718 0.294 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 159.91 26.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.246 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.51 179.35 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.44 32.26 21.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.049 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.98 -16.47 60.84 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.86 11.49 4.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 7' ' ' PRO . 1.9 m-85 -100.07 0.15 40.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.789 0.294 . . . . 0.0 111.324 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -138.15 115.88 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 105.27 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -89.87 176.61 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -175.2 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.941 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 61.29 56.39 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.34 51.72 0.49 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -176.04 99.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 0.0 110.781 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.58 -49.2 16.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.29 -141.48 8.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' CD ' ' CE1' ' A' ' 35' ' ' PHE . 45.9 Cg_endo -68.57 -46.95 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.635 2.223 . . . . 0.0 112.521 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 45.0 p90 -57.71 -40.42 79.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -153.78 151.88 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -175.27 157.6 2.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -145.63 145.47 30.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.741 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.82 -46.83 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.05 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -51.82 66.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.2 t -75.77 -30.83 59.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.02 -39.47 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.946 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -59.78 -51.18 70.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -59.6 -31.09 69.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -75.29 -30.48 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.3 m -58.99 -31.14 68.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 25' ' ' TYR . 23.2 mt -85.56 139.98 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 142.68 36.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.33 13.79 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 21.3 m-85 -76.29 -178.31 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 -58.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.25 -169.79 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.19 172.56 27.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -164.1 145.3 8.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.824 0.345 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.0 m -69.99 122.06 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.81 165.71 11.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 60.9 70.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 56.26 36.25 68.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.641 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.49 52.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.441 ' CE1' ' CD ' ' A' ' 7' ' ' PRO . 85.6 m-85 -100.09 -25.55 14.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.0 t -113.15 159.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.19 138.76 54.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -142.95 154.32 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.418 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 79.8 m -116.99 156.1 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 59.5 60.3 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.965 0.412 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 19.1 43.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.937 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.59 100.05 10.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 0.0 110.755 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -99.63 29.91 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.9 -150.69 46.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.64 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.97 -20.86 46.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.57 -64.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.958 0.408 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -152.69 148.07 26.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.734 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.67 149.78 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.33 178.52 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.22 -28.44 12.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.3 mtp -99.55 -24.77 14.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.44 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -62.94 1.31 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -59.36 -31.58 69.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.405 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 13.5 t60 -68.29 -26.79 65.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -70.44 -51.02 32.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.238 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -49.96 -63.47 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 m -54.19 -26.15 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -29.0 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -97.16 37.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 22' ' ' ILE . 31.6 mt -137.92 152.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -64.72 128.35 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.173 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -58.02 5.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.761 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.418 ' CG ' ' HB3' ' A' ' 39' ' ' CYS . 5.1 m-30 -53.53 169.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 111.294 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 -55.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . -163.3 -88.41 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.24 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.0 -152.15 24.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.634 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -150.44 -177.6 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.98 157.64 18.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.25 158.8 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 62.28 70.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.42 69.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.642 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.14 31.01 77.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.539 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -32.57 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.948 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.2 152.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.195 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 118.32 31.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.9 161.0 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.418 ' HB3' ' CG ' ' A' ' 25' ' ' TYR . 74.4 m -138.0 151.55 48.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.775 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 60.6 30.82 20.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.04 -28.57 3.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.41 124.18 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.64 77.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.54 160.34 29.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.608 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.424 ' HD2' ' CE3' ' A' ' 8' ' ' TRP . 22.5 Cg_exo -64.57 -40.59 22.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.424 ' CE3' ' HD2' ' A' ' 7' ' ' PRO . 25.0 p90 -62.44 -47.08 85.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.265 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -116.9 125.22 51.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -161.78 175.92 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.89 132.33 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -49.19 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -37.59 77.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -59.68 -53.83 53.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -23.59 59.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.021 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -46.06 80.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.009 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -58.42 -41.16 84.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -64.2 -48.86 74.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.56 -44.36 90.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -58.49 -23.25 57.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.03 38.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 25' ' ' TYR . 53.6 mt -146.59 103.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tttm 50.38 31.22 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.5 -82.55 1.38 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 21.9 m-30 55.41 -177.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.866 0.365 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -128.25 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.62 -143.82 16.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.78 -176.75 47.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -138.75 157.95 45.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 m -82.06 111.2 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.96 151.68 21.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 30.33 12.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.007 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.91 -21.89 34.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.65 -19.11 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.659 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.61 -25.6 27.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 0.0 111.125 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.25 116.54 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 104.85 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.66 173.18 7.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.0 m -131.57 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.92 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 60.91 37.23 18.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.381 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.57 84.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 109.35 21.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -97.54 36.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.19 -145.58 49.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.39 -8.66 23.81 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 0.0 112.621 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -66.87 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.16 100.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.13 159.36 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.47 150.19 30.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.19 -26.48 13.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 ttm -94.12 -33.29 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -45.74 89.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.0 t -82.03 -36.96 27.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.8 -53.67 50.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -57.92 -30.88 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -65.24 -41.2 94.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.2 m -70.55 -41.06 72.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -26.31 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -91.71 47.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.444 ' CG2' ' CD1' ' A' ' 25' ' ' TYR . 31.8 mt -142.89 156.83 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.077 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -79.84 106.8 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.57 10.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.546 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 22' ' ' ILE . 6.5 m-85 -128.21 151.46 49.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 -42.42 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.47 -165.34 33.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 165.19 -158.46 31.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.554 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.86 -165.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.324 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 163.33 13.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.039 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.61 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt 61.12 32.36 19.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.06 -19.28 54.05 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.19 0.91 5.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.093 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -87.15 0.04 55.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 111.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.62 110.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.25 24.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.705 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -106.92 178.41 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m -149.71 165.36 32.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.438 ' CE2' ' HA2' ' A' ' 28' ' ' GLY . 35.2 p90 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 15' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.6 m-30 71.85 38.54 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.97 2.04 5.12 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.805 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 100.02 10.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -61.49 -59.48 5.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.48 -169.26 42.39 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.454 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.11 -30.02 68.61 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.518 2.146 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -74.08 -48.61 28.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.041 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.76 143.36 47.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.6 159.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -135.38 134.2 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.622 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.13 -45.42 73.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -10.1 59.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.455 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' HB2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -59.25 -59.07 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 111.088 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.435 ' HA ' ' CA ' ' A' ' 1' ' ' GLY . 22.9 m -59.41 -43.84 92.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.857 0.36 . . . . 0.0 110.784 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -50.83 -27.17 6.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.326 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -59.24 -52.85 63.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -79.91 -33.2 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.4 m -54.82 -34.1 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -31.15 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -62.29 -18.27 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HB ' ' CG ' ' A' ' 25' ' ' TYR . 1.6 mm -77.26 167.12 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -97.29 119.16 35.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.84 18.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.601 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.427 ' CG ' ' HB ' ' A' ' 22' ' ' ILE . 4.1 m-30 -58.63 177.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 31.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.11 -176.6 48.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.23 -135.99 2.27 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -170.78 173.62 5.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 m -70.51 152.96 43.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.75 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.59 35.42 20.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.974 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.12 -1.61 86.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.883 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 18.62 6.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.709 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.21 -27.73 13.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.04 155.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.434 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 11.6 m -110.01 132.39 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.517 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -108.53 149.66 28.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.049 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 9.8 m -146.11 152.93 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.947 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 58.41 28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.68 0.276 . . . . 0.0 111.003 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.98 -34.57 2.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 109.49 21.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -84.78 -41.4 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.29 -150.83 22.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.601 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.24 -13.58 36.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.776 2.317 . . . . 0.0 112.787 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -29.28 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.268 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -159.74 148.27 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -176.96 118.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.4 158.42 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -98.77 -30.68 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -30.49 29.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -58.14 -31.93 67.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.7 m -91.42 -35.36 14.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -64.09 -47.3 80.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -56.58 -27.71 58.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.54 -24.75 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.2 t -77.07 -71.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -23.28 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -31.39 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.7 mt -75.83 158.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.074 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.6 mttm -88.56 85.0 6.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.93 -28.15 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.21 172.03 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -129.91 -56.27 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.787 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 167.09 40.19 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.267 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.76 -163.27 9.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -160.66 177.06 10.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.41 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 32.8 m -96.13 105.67 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -101.15 179.93 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 65.0 33.61 9.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.36 81.28 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.975 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 120.44 9.97 7.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -100.09 -33.23 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 111.041 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 75.4 t -100.84 154.39 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.439 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -139.84 89.84 2.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.069 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.07 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.295 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.9 m -138.43 -174.2 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.093 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 60.34 31.33 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.775 0.322 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.22 -25.96 20.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.594 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 99.97 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.583 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.77 -48.51 12.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.78 -156.17 24.41 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.51 -36.88 3.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.605 2.203 . . . . 0.0 112.42 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.23 -29.45 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -156.14 140.55 16.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.18 162.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.003 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -118.1 142.85 46.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -100.1 -29.79 12.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -33.21 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -59.48 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -23.06 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.411 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 79.9 t60 -81.6 -40.53 22.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.066 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.74 -58.75 6.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -55.33 -40.83 71.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -58.81 -41.88 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -43.13 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -22.54 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 22' ' ' ILE . 29.3 mt -63.98 162.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -43.29 89.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 44.11 27.11 1.02 Allowed Glycine 0 CA--C 1.521 0.424 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.039 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.471 ' CG ' ' HB ' ' A' ' 22' ' ' ILE . 3.4 m-30 -57.09 159.13 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.141 0.471 . . . . 0.0 110.599 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -103.08 36.41 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . 70.85 152.8 1.0 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.16 -169.02 14.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.44 166.32 6.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 130.18 41.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.0 174.15 8.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.089 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.15 35.26 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.66 -20.61 48.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.63 8.0 5.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.045 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 0.23 40.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.8 0.3 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.99 157.79 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 111.268 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 105.3 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -107.57 152.01 24.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.449 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 19.9 m -123.24 -175.97 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.996 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 2.1 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.882 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 59.68 31.64 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.42 -34.95 2.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 100.06 10.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -109.63 92.05 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.28 152.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.567 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.87 -26.03 23.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.616 2.211 . . . . 0.0 112.4 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.406 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 12.5 p90 -69.18 -34.06 74.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.026 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 6.1 m-20 -132.55 123.76 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.74 144.81 20.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.99 148.47 50.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -100.07 -44.92 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mmt -74.83 -35.22 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.57 -34.73 69.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.15 -27.89 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -75.17 -47.76 26.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -65.7 -42.02 91.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.38 -49.7 76.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.092 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.9 m -59.21 -40.85 87.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.28 -28.35 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -10.42 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HB ' ' CD1' ' A' ' 25' ' ' TYR . 7.5 mt -89.13 165.08 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.657 0.265 . . . . 0.0 111.025 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -41.2 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 43.49 73.02 0.27 Allowed Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.079 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.47 ' CD1' ' HB ' ' A' ' 22' ' ' ILE . 3.2 m-85 -103.71 163.74 12.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 12.3 mttm -122.24 43.51 2.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -171.46 30.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.29 -141.32 3.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.86 -166.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.0 m -101.98 117.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.38 153.58 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.051 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? 58.6 37.53 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.23 -81.55 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.91 26.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.536 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -100.15 -38.45 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.0 t -114.57 159.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.86 112.9 9.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.771 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -114.35 154.57 27.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -170.35 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.721 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CZ ' ' O ' ' A' ' 26' ' ' LYS . 6.1 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.848 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 59.06 26.14 14.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.99 -26.5 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -99.96 99.98 10.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.82 0.343 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -89.8 -38.31 13.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.409 ' HA2' ' CD1' ' A' ' 35' ' ' PHE . . . -165.29 169.63 39.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.522 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.422 ' HD2' ' CZ3' ' A' ' 8' ' ' TRP . 60.1 Cg_exo -51.66 -33.68 50.16 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.422 ' CZ3' ' HD2' ' A' ' 7' ' ' PRO . 45.9 p90 -87.9 -33.75 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.17 111.02 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -157.58 173.73 16.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.024 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 159.53 38.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -100.21 -38.8 8.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.9 mmt -99.67 -29.57 12.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.376 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.41 -34.57 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.03 -29.33 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.41 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 33.5 t60 -73.74 -46.32 46.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.975 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.36 -45.93 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -63.25 -47.76 81.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.18 -30.15 71.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -32.57 68.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -28.26 65.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.078 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.33 157.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.29 147.48 25.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.69 -35.61 4.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.575 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -102.21 165.31 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -119.05 31.06 6.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.41 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . 138.71 -159.1 25.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.67 167.84 39.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.7 161.64 13.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 82.2 m -86.34 109.91 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 36' ' ' VAL . . . -89.9 -178.68 5.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.973 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.6 mttp 49.76 69.1 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.44 54.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.173 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 74.31 16.1 79.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.409 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 1.8 t80 -100.29 0.21 39.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' ALA . 87.7 t -142.02 114.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.703 0.287 . . . . 0.0 111.446 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.82 138.84 31.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.629 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.66 178.46 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.409 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -118.22 120.86 38.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.875 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 59.97 59.97 2.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.89 28.65 11.84 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 108.15 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.747 0.308 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HB3' ' CH2' ' A' ' 8' ' ' TRP . 18.6 m-80 -124.46 39.86 3.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.23 -149.91 38.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.57 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.41 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -72.89 -41.8 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.673 2.249 . . . . 0.0 112.529 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -57.83 -28.62 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -159.46 136.51 9.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.909 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -178.15 138.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.03 161.39 26.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -100.09 -33.66 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.228 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.13 -26.61 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.265 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -58.71 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.021 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.41 -30.12 71.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.432 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 13.4 t60 -57.7 -44.4 85.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.83 -45.6 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.07 -59.71 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.7 t -71.48 -10.03 59.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.591 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -42.46 63.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 110.655 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 57.87 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.4 mt -144.37 141.84 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.0 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.39 128.12 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -63.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.615 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 1.5 m-85 -62.65 142.81 57.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 -33.64 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.432 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . -142.04 -134.7 3.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.11 156.5 14.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -155.36 -173.59 4.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.718 0.294 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 159.91 26.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.246 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.51 179.35 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.44 32.26 21.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.049 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.98 -16.47 60.84 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.86 11.49 4.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.41 ' CE2' ' HD3' ' A' ' 7' ' ' PRO . 1.9 m-85 -100.07 0.15 40.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.789 0.294 . . . . 0.0 111.324 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -138.15 115.88 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 105.27 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -89.87 176.61 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -175.2 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.941 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.953 0.406 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.34 51.72 0.49 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -176.04 99.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 0.0 110.781 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.58 -49.2 16.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.29 -141.48 8.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' CE1' ' A' ' 35' ' ' PHE . 45.9 Cg_endo -68.57 -46.95 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.635 2.223 . . . . 0.0 112.521 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 45.0 p90 -57.71 -40.42 79.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -153.78 151.88 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -175.27 157.6 2.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -145.63 145.47 30.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.741 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.82 -46.83 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.05 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -51.82 66.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.2 t -75.77 -30.83 59.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.02 -39.47 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.946 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -59.78 -51.18 70.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -59.6 -31.09 69.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -75.29 -30.48 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.3 m -58.99 -31.14 68.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.56 139.98 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 142.68 36.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.33 13.79 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 21.3 m-85 -76.29 -178.31 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 -58.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.25 -169.79 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.19 172.56 27.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -164.1 145.3 8.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.824 0.345 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.0 m -69.99 122.06 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.81 165.71 11.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 60.9 70.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 56.26 36.25 68.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.641 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.49 52.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 7' ' ' PRO . 85.6 m-85 -100.09 -25.55 14.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 37' ' ' CYS . 43.0 t -113.15 159.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.492 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -125.19 138.76 54.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -142.95 154.32 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 79.8 m -116.99 156.1 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.965 0.412 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 19.1 43.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.937 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.59 100.05 10.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 0.0 110.755 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -99.63 29.91 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.9 -150.69 46.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.64 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.97 -20.86 46.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.57 -64.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.958 0.408 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -152.69 148.07 26.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.734 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.67 149.78 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.33 178.52 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.22 -28.44 12.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.3 mtp -99.55 -24.77 14.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.44 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -62.94 1.31 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -59.36 -31.58 69.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 13.5 t60 -68.29 -26.79 65.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -70.44 -51.02 32.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.238 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -49.96 -63.47 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 m -54.19 -26.15 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -29.0 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -97.16 37.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.487 HG21 ' CE2' ' A' ' 25' ' ' TYR . 31.6 mt -137.92 152.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -64.72 128.35 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.173 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -58.02 5.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.761 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CE2' HG21 ' A' ' 22' ' ' ILE . 5.1 m-30 -53.53 169.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 111.294 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 -55.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . -163.3 -88.41 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.24 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.0 -152.15 24.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.634 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -150.44 -177.6 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.98 157.64 18.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.25 158.8 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 62.28 70.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.42 69.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.642 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.14 31.01 77.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.539 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -32.57 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.948 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.2 152.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.195 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 118.32 31.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.9 161.0 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' CG ' ' A' ' 25' ' ' TYR . 74.4 m -138.0 151.55 48.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.775 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.914 0.388 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.04 -28.57 3.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.41 124.18 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.64 77.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.54 160.34 29.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.608 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.427 ' HD2' ' CE3' ' A' ' 8' ' ' TRP . 22.5 Cg_exo -64.57 -40.59 22.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.427 ' CE3' ' HD2' ' A' ' 7' ' ' PRO . 25.0 p90 -62.44 -47.08 85.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.265 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -116.9 125.22 51.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -161.78 175.92 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.89 132.33 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -49.19 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -37.59 77.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -59.68 -53.83 53.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -23.59 59.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.021 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -46.06 80.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.009 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -58.42 -41.16 84.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -64.2 -48.86 74.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.56 -44.36 90.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -58.49 -23.25 57.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.03 38.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 25' ' ' TYR . 53.6 mt -146.59 103.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tttm 50.38 31.22 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.5 -82.55 1.38 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 21.9 m-30 55.41 -177.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.866 0.365 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -128.25 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.62 -143.82 16.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.78 -176.75 47.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -138.75 157.95 45.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 m -82.06 111.2 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.96 151.68 21.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 30.33 12.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.007 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.91 -21.89 34.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.65 -19.11 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.659 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.61 -25.6 27.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 0.0 111.125 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.25 116.54 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 104.85 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.66 173.18 7.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.0 m -131.57 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.92 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.899 0.381 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.57 84.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 109.35 21.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -97.54 36.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.19 -145.58 49.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.39 -8.66 23.81 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 0.0 112.621 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -66.87 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.16 100.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.13 159.36 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.47 150.19 30.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.19 -26.48 13.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 ttm -94.12 -33.29 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -45.74 89.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.0 t -82.03 -36.96 27.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.8 -53.67 50.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -57.92 -30.88 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -65.24 -41.2 94.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.2 m -70.55 -41.06 72.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -26.31 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -91.71 47.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 23' ' ' LYS . 31.8 mt -142.89 156.83 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.077 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 22' ' ' ILE . 3.1 pttp -79.84 106.8 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.57 10.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.546 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 22' ' ' ILE . 6.5 m-85 -128.21 151.46 49.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 -42.42 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.47 -165.34 33.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 165.19 -158.46 31.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.554 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.86 -165.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.324 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 163.33 13.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.039 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.61 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 36' ' ' VAL . 2.8 mtmt 61.12 32.36 19.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.06 -19.28 54.05 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.19 0.91 5.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.093 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -87.15 0.04 55.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 111.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 32' ' ' LYS . 39.5 t -140.62 110.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.25 24.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.705 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HD3' HG12 ' A' ' 36' ' ' VAL . 10.6 mmmm -106.92 178.41 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m -149.71 165.36 32.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.453 ' CE2' ' HA2' ' A' ' 28' ' ' GLY . 35.2 p90 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.6 m-30 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.97 2.04 5.12 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.805 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 100.02 10.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -61.49 -59.48 5.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.48 -169.26 42.39 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.454 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.11 -30.02 68.61 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.518 2.146 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -74.08 -48.61 28.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.041 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.76 143.36 47.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.6 159.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -135.38 134.2 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.622 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.13 -45.42 73.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -10.1 59.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.455 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -59.25 -59.07 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 111.088 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.9 m -59.41 -43.84 92.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.857 0.36 . . . . 0.0 110.784 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -50.83 -27.17 6.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.326 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -59.24 -52.85 63.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -79.91 -33.2 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.4 m -54.82 -34.1 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -31.15 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -62.29 -18.27 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.6 mm -77.26 167.12 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 22' ' ' ILE . 11.0 mmmm -97.29 119.16 35.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.84 18.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.601 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 39' ' ' CYS . 4.1 m-30 -58.63 177.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 31.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.11 -176.6 48.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.23 -135.99 2.27 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -170.78 173.62 5.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 m -70.51 152.96 43.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.75 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.59 35.42 20.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.974 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.12 -1.61 86.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.883 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 18.62 6.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.709 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.21 -27.73 13.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 37' ' ' CYS . 41.9 t -120.04 155.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.434 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . 11.6 m -110.01 132.39 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -108.53 149.66 28.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.049 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 9.8 m -146.11 152.93 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.947 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.68 0.276 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.98 -34.57 2.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 109.49 21.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -84.78 -41.4 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.29 -150.83 22.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.601 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.24 -13.58 36.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.776 2.317 . . . . 0.0 112.787 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -29.28 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.268 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -159.74 148.27 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -176.96 118.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.4 158.42 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -98.77 -30.68 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -30.49 29.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -58.14 -31.93 67.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.7 m -91.42 -35.36 14.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -64.09 -47.3 80.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -56.58 -27.71 58.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.54 -24.75 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.2 t -77.07 -71.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -23.28 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -31.39 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 23' ' ' LYS . 25.7 mt -75.83 158.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.074 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 22' ' ' ILE . 13.6 mttm -88.56 85.0 6.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.93 -28.15 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.21 172.03 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -129.91 -56.27 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.787 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 167.09 40.19 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.267 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.76 -163.27 9.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -160.66 177.06 10.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 32.8 m -96.13 105.67 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . . . -101.15 179.93 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.178 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' HD2' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 65.0 33.61 9.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.36 81.28 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.975 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 120.44 9.97 7.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -100.09 -33.23 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 111.041 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 32' ' ' LYS . 75.4 t -100.84 154.39 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.439 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.44 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.84 89.84 2.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.069 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.07 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.295 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.9 m -138.43 -174.2 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.775 0.322 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.22 -25.96 20.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.594 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 99.97 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.583 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.77 -48.51 12.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.78 -156.17 24.41 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.51 -36.88 3.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.605 2.203 . . . . 0.0 112.42 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.23 -29.45 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -156.14 140.55 16.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.18 162.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.003 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -118.1 142.85 46.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -100.1 -29.79 12.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -33.21 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -59.48 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -23.06 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -81.6 -40.53 22.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.066 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.74 -58.75 6.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -55.33 -40.83 71.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -58.81 -41.88 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -43.13 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -22.54 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.647 HG21 ' CE2' ' A' ' 25' ' ' TYR . 29.3 mt -63.98 162.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.549 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -43.29 89.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 44.11 27.11 1.02 Allowed Glycine 0 CA--C 1.521 0.424 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.039 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 22' ' ' ILE . 3.4 m-30 -57.09 159.13 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.141 0.471 . . . . 0.0 110.599 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -103.08 36.41 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.85 152.8 1.0 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.356 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.16 -169.02 14.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.44 166.32 6.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 130.18 41.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.0 174.15 8.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.089 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.15 35.26 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.66 -20.61 48.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.63 8.0 5.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.045 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 0.23 40.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.8 0.3 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 37' ' ' CYS . 40.2 t -135.99 157.79 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 111.268 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.477 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.95 105.3 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -107.57 152.01 24.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 19.9 m -123.24 -175.97 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.996 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 2.1 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.882 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.42 -34.95 2.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 100.06 10.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -109.63 92.05 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.28 152.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.567 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.87 -26.03 23.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.616 2.211 . . . . 0.0 112.4 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -69.18 -34.06 74.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.026 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.55 123.76 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.74 144.81 20.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.99 148.47 50.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -100.07 -44.92 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mmt -74.83 -35.22 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.57 -34.73 69.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.15 -27.89 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -75.17 -47.76 26.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -65.7 -42.02 91.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.38 -49.7 76.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.092 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.9 m -59.21 -40.85 87.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.28 -28.35 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -10.42 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.474 ' HB ' ' CD1' ' A' ' 25' ' ' TYR . 7.5 mt -89.13 165.08 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.657 0.265 . . . . 0.0 111.025 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' H ' HG22 ' A' ' 22' ' ' ILE . 12.7 tttp -41.2 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 43.49 73.02 0.27 Allowed Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.079 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CD1' ' HB ' ' A' ' 22' ' ' ILE . 3.2 m-85 -103.71 163.74 12.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 12.3 mttm -122.24 43.51 2.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -171.46 30.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.29 -141.32 3.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.86 -166.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.0 m -101.98 117.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.38 153.58 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.051 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? 58.6 37.53 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.23 -81.55 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.91 26.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.536 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -100.15 -38.45 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 37' ' ' CYS . 13.0 t -114.57 159.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -137.86 112.9 9.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.771 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -114.35 154.57 27.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -170.35 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.721 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CZ ' ' O ' ' A' ' 26' ' ' LYS . 6.1 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.848 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.99 -26.5 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -99.96 99.98 10.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.82 0.343 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -89.8 -38.31 13.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 35' ' ' PHE . . . -165.29 169.63 39.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.522 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD2' ' CZ3' ' A' ' 8' ' ' TRP . 60.1 Cg_exo -51.66 -33.68 50.16 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.423 ' CZ3' ' HD2' ' A' ' 7' ' ' PRO . 45.9 p90 -87.9 -33.75 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.17 111.02 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -157.58 173.73 16.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.024 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 159.53 38.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -100.21 -38.8 8.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.9 mmt -99.67 -29.57 12.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.376 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.41 -34.57 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.03 -29.33 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 33.5 t60 -73.74 -46.32 46.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.975 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.36 -45.93 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -63.25 -47.76 81.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.18 -30.15 71.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -32.57 68.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -28.26 65.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.078 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' LYS . 19.7 mt -89.33 157.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -100.29 147.48 25.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.69 -35.61 4.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.575 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -102.21 165.31 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -119.05 31.06 6.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . 138.71 -159.1 25.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.67 167.84 39.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.7 161.64 13.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 82.2 m -86.34 109.91 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . . . -89.9 -178.68 5.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.973 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.6 mttp 49.76 69.1 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.44 54.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.173 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 74.31 16.1 79.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 1.8 t80 -100.29 0.21 39.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' ALA . 87.7 t -142.02 114.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.703 0.287 . . . . 0.0 111.446 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.82 138.84 31.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.629 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -145.66 178.46 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -118.22 120.86 38.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.875 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.89 28.65 11.84 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 108.15 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.747 0.308 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 8' ' ' TRP . 18.6 m-80 -124.46 39.86 3.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.23 -149.91 38.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.57 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -72.89 -41.8 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.673 2.249 . . . . 0.0 112.529 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -57.83 -28.62 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -159.46 136.51 9.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.909 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -178.15 138.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.03 161.39 26.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -100.09 -33.66 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.228 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.13 -26.61 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.265 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -58.71 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.021 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.41 -30.12 71.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.454 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 13.4 t60 -57.7 -44.4 85.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.83 -45.6 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.07 -59.71 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' HA ' HD12 ' A' ' 22' ' ' ILE . 48.7 t -71.48 -10.03 59.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.591 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -42.46 63.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 110.655 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 57.87 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 19' ' ' CYS . 27.4 mt -144.37 141.84 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.0 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.39 128.12 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -63.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.615 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 1.5 m-85 -62.65 142.81 57.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 -33.64 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . -142.04 -134.7 3.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.11 156.5 14.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -155.36 -173.59 4.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.718 0.294 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 159.91 26.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.246 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.51 179.35 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER 59.44 32.26 21.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.049 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.98 -16.47 60.84 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.86 11.49 4.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HD3' ' A' ' 7' ' ' PRO . 1.9 m-85 -100.07 0.15 40.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.789 0.294 . . . . 0.0 111.324 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' ' 32' ' ' LYS . 60.7 t -138.15 115.88 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 105.27 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -89.87 176.61 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -175.2 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.941 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.598 ' H3 ' ' HB3' ' A' ' 18' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 61.29 56.39 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.34 51.72 0.49 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -176.04 99.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 0.0 110.781 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.58 -49.2 16.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.29 -141.48 8.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' CE1' ' A' ' 35' ' ' PHE . 45.9 Cg_endo -68.57 -46.95 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.635 2.223 . . . . 0.0 112.521 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 45.0 p90 -57.71 -40.42 79.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -153.78 151.88 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -175.27 157.6 2.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -145.63 145.47 30.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.741 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.82 -46.83 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.05 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -51.82 66.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.2 t -75.77 -30.83 59.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.02 -39.47 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.946 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.598 ' HB3' ' H3 ' ' A' ' 1' ' ' GLY . 47.1 t-80 -59.78 -51.18 70.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -59.6 -31.09 69.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -75.29 -30.48 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.3 m -58.99 -31.14 68.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.56 139.98 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 142.68 36.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.33 13.79 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 21.3 m-85 -76.29 -178.31 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 -58.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.25 -169.79 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.19 172.56 27.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -164.1 145.3 8.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.824 0.345 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.0 m -69.99 122.06 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.81 165.71 11.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 60.9 70.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 56.26 36.25 68.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.641 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.49 52.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 7' ' ' PRO . 85.6 m-85 -100.09 -25.55 14.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 37' ' ' CYS . 43.0 t -113.15 159.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.492 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -125.19 138.76 54.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -142.95 154.32 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 79.8 m -116.99 156.1 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 59.5 60.3 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.965 0.412 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 19.1 43.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.937 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.59 100.05 10.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 0.0 110.755 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -99.63 29.91 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.9 -150.69 46.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.64 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.97 -20.86 46.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.57 -64.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.958 0.408 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -152.69 148.07 26.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.734 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.67 149.78 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.33 178.52 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.22 -28.44 12.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.3 mtp -99.55 -24.77 14.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.44 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -62.94 1.31 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -59.36 -31.58 69.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 13.5 t60 -68.29 -26.79 65.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -70.44 -51.02 32.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.238 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -49.96 -63.47 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 m -54.19 -26.15 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -29.0 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -97.16 37.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.487 HG21 ' CE2' ' A' ' 25' ' ' TYR . 31.6 mt -137.92 152.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -64.72 128.35 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.173 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -58.02 5.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.761 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CE2' HG21 ' A' ' 22' ' ' ILE . 5.1 m-30 -53.53 169.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 111.294 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 -55.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . -163.3 -88.41 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.24 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.0 -152.15 24.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.634 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -150.44 -177.6 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.98 157.64 18.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.25 158.8 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 62.28 70.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.42 69.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.642 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.14 31.01 77.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.539 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -32.57 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.948 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.2 152.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.195 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 118.32 31.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.9 161.0 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' CG ' ' A' ' 25' ' ' TYR . 74.4 m -138.0 151.55 48.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.775 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 60.6 30.82 20.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.04 -28.57 3.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.41 124.18 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.64 77.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.54 160.34 29.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.608 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.427 ' HD2' ' CE3' ' A' ' 8' ' ' TRP . 22.5 Cg_exo -64.57 -40.59 22.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.427 ' CE3' ' HD2' ' A' ' 7' ' ' PRO . 25.0 p90 -62.44 -47.08 85.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.265 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -116.9 125.22 51.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -161.78 175.92 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.89 132.33 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -49.19 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -37.59 77.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -59.68 -53.83 53.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -23.59 59.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.021 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -46.06 80.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.009 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -58.42 -41.16 84.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -64.2 -48.86 74.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.56 -44.36 90.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -58.49 -23.25 57.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.03 38.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 25' ' ' TYR . 53.6 mt -146.59 103.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tttm 50.38 31.22 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.5 -82.55 1.38 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 21.9 m-30 55.41 -177.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.866 0.365 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -128.25 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.62 -143.82 16.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.78 -176.75 47.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -138.75 157.95 45.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 m -82.06 111.2 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.96 151.68 21.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 30.33 12.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.007 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.91 -21.89 34.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.65 -19.11 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.659 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.61 -25.6 27.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 0.0 111.125 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.25 116.54 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 104.85 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.66 173.18 7.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.0 m -131.57 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.92 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 60.91 37.23 18.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.381 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.57 84.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 109.35 21.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -97.54 36.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.19 -145.58 49.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.39 -8.66 23.81 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 0.0 112.621 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -66.87 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.16 100.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.13 159.36 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.47 150.19 30.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.19 -26.48 13.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 ttm -94.12 -33.29 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -45.74 89.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.0 t -82.03 -36.96 27.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.8 -53.67 50.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -57.92 -30.88 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -65.24 -41.2 94.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.2 m -70.55 -41.06 72.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -26.31 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -91.71 47.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 23' ' ' LYS . 31.8 mt -142.89 156.83 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.077 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 22' ' ' ILE . 3.1 pttp -79.84 106.8 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.57 10.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.546 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 22' ' ' ILE . 6.5 m-85 -128.21 151.46 49.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 -42.42 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.47 -165.34 33.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 165.19 -158.46 31.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.554 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.86 -165.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.324 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 163.33 13.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.039 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.61 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 36' ' ' VAL . 2.8 mtmt 61.12 32.36 19.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.06 -19.28 54.05 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.19 0.91 5.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.093 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -87.15 0.04 55.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 111.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 32' ' ' LYS . 39.5 t -140.62 110.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.25 24.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.705 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HD3' HG12 ' A' ' 36' ' ' VAL . 10.6 mmmm -106.92 178.41 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m -149.71 165.36 32.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.453 ' CE2' ' HA2' ' A' ' 28' ' ' GLY . 35.2 p90 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 15' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.6 m-30 71.85 38.54 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.97 2.04 5.12 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.805 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 100.02 10.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -61.49 -59.48 5.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.48 -169.26 42.39 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.454 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.11 -30.02 68.61 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.518 2.146 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -74.08 -48.61 28.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.041 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.76 143.36 47.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.6 159.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -135.38 134.2 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.622 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.13 -45.42 73.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -10.1 59.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.455 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -59.25 -59.07 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 111.088 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 1' ' ' GLY . 22.9 m -59.41 -43.84 92.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.857 0.36 . . . . 0.0 110.784 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -50.83 -27.17 6.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.326 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -59.24 -52.85 63.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -79.91 -33.2 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.4 m -54.82 -34.1 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -31.15 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -62.29 -18.27 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.6 mm -77.26 167.12 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 22' ' ' ILE . 11.0 mmmm -97.29 119.16 35.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.84 18.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.601 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 39' ' ' CYS . 4.1 m-30 -58.63 177.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 31.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.11 -176.6 48.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.23 -135.99 2.27 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -170.78 173.62 5.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 m -70.51 152.96 43.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.75 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.59 35.42 20.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.974 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.12 -1.61 86.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.883 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 18.62 6.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.709 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.21 -27.73 13.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 37' ' ' CYS . 41.9 t -120.04 155.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.434 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . 11.6 m -110.01 132.39 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -108.53 149.66 28.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.049 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 9.8 m -146.11 152.93 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.947 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 58.41 28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.68 0.276 . . . . 0.0 111.003 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.98 -34.57 2.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 109.49 21.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -84.78 -41.4 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.29 -150.83 22.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.601 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.24 -13.58 36.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.776 2.317 . . . . 0.0 112.787 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -29.28 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.268 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -159.74 148.27 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -176.96 118.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.4 158.42 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -98.77 -30.68 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -30.49 29.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -58.14 -31.93 67.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.7 m -91.42 -35.36 14.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -64.09 -47.3 80.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -56.58 -27.71 58.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.54 -24.75 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.2 t -77.07 -71.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -23.28 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -31.39 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 23' ' ' LYS . 25.7 mt -75.83 158.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.074 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 22' ' ' ILE . 13.6 mttm -88.56 85.0 6.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.93 -28.15 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.21 172.03 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -129.91 -56.27 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.787 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 167.09 40.19 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.267 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.76 -163.27 9.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -160.66 177.06 10.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 32.8 m -96.13 105.67 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . . . -101.15 179.93 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.178 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' HD2' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 65.0 33.61 9.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.36 81.28 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.975 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 120.44 9.97 7.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -100.09 -33.23 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 111.041 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 32' ' ' LYS . 75.4 t -100.84 154.39 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.439 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.84 89.84 2.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.069 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.07 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.295 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.9 m -138.43 -174.2 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.093 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 60.34 31.33 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.775 0.322 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.22 -25.96 20.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.594 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 99.97 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.583 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.77 -48.51 12.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.78 -156.17 24.41 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.51 -36.88 3.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.605 2.203 . . . . 0.0 112.42 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.23 -29.45 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -156.14 140.55 16.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.18 162.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.003 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -118.1 142.85 46.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -100.1 -29.79 12.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -33.21 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -59.48 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -23.06 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -81.6 -40.53 22.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.066 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.74 -58.75 6.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -55.33 -40.83 71.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -58.81 -41.88 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -43.13 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -22.54 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.647 HG21 ' CE2' ' A' ' 25' ' ' TYR . 29.3 mt -63.98 162.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.549 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -43.29 89.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 44.11 27.11 1.02 Allowed Glycine 0 CA--C 1.521 0.424 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.039 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 22' ' ' ILE . 3.4 m-30 -57.09 159.13 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.141 0.471 . . . . 0.0 110.599 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -103.08 36.41 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.85 152.8 1.0 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.356 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.16 -169.02 14.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.44 166.32 6.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 130.18 41.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.0 174.15 8.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.089 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.15 35.26 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.66 -20.61 48.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.63 8.0 5.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.045 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 0.23 40.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.8 0.3 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 37' ' ' CYS . 40.2 t -135.99 157.79 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 111.268 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.477 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.95 105.3 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -107.57 152.01 24.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 19.9 m -123.24 -175.97 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.996 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 2.1 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.882 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 59.68 31.64 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.42 -34.95 2.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 100.06 10.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -109.63 92.05 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.28 152.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.567 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.87 -26.03 23.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.616 2.211 . . . . 0.0 112.4 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -69.18 -34.06 74.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.026 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.55 123.76 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.74 144.81 20.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.99 148.47 50.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -100.07 -44.92 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mmt -74.83 -35.22 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.57 -34.73 69.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.15 -27.89 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -75.17 -47.76 26.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -65.7 -42.02 91.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.38 -49.7 76.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.092 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.9 m -59.21 -40.85 87.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.28 -28.35 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -10.42 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.474 ' HB ' ' CD1' ' A' ' 25' ' ' TYR . 7.5 mt -89.13 165.08 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.657 0.265 . . . . 0.0 111.025 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' H ' HG22 ' A' ' 22' ' ' ILE . 12.7 tttp -41.2 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 43.49 73.02 0.27 Allowed Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.079 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CD1' ' HB ' ' A' ' 22' ' ' ILE . 3.2 m-85 -103.71 163.74 12.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 12.3 mttm -122.24 43.51 2.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -171.46 30.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.29 -141.32 3.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.86 -166.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.0 m -101.98 117.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.38 153.58 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.051 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? 58.6 37.53 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.23 -81.55 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.91 26.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.536 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -100.15 -38.45 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 37' ' ' CYS . 13.0 t -114.57 159.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -137.86 112.9 9.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.771 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -114.35 154.57 27.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -170.35 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.721 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CZ ' ' O ' ' A' ' 26' ' ' LYS . 6.1 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.848 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 59.06 26.14 14.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.99 -26.5 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -99.96 99.98 10.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.82 0.343 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -89.8 -38.31 13.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 35' ' ' PHE . . . -165.29 169.63 39.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.522 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD2' ' CZ3' ' A' ' 8' ' ' TRP . 60.1 Cg_exo -51.66 -33.68 50.16 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.423 ' CZ3' ' HD2' ' A' ' 7' ' ' PRO . 45.9 p90 -87.9 -33.75 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.17 111.02 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -157.58 173.73 16.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.024 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 159.53 38.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -100.21 -38.8 8.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.9 mmt -99.67 -29.57 12.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.376 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.41 -34.57 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.03 -29.33 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 33.5 t60 -73.74 -46.32 46.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.975 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.36 -45.93 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -63.25 -47.76 81.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.18 -30.15 71.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -32.57 68.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -28.26 65.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.078 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' LYS . 19.7 mt -89.33 157.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -100.29 147.48 25.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.69 -35.61 4.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.575 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -102.21 165.31 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -119.05 31.06 6.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . 138.71 -159.1 25.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.67 167.84 39.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.7 161.64 13.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 82.2 m -86.34 109.91 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . . . -89.9 -178.68 5.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.973 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.6 mttp 49.76 69.1 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.44 54.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.173 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 74.31 16.1 79.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 1.8 t80 -100.29 0.21 39.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' ALA . 87.7 t -142.02 114.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.703 0.287 . . . . 0.0 111.446 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.82 138.84 31.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.629 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -145.66 178.46 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -118.22 120.86 38.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.875 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 59.97 59.97 2.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.89 28.65 11.84 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 108.15 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.747 0.308 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 8' ' ' TRP . 18.6 m-80 -124.46 39.86 3.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.23 -149.91 38.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.57 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -72.89 -41.8 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.673 2.249 . . . . 0.0 112.529 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -57.83 -28.62 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -159.46 136.51 9.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.909 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -178.15 138.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.03 161.39 26.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -100.09 -33.66 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.228 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.13 -26.61 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.265 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -58.71 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.021 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.41 -30.12 71.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.454 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 13.4 t60 -57.7 -44.4 85.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.83 -45.6 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.07 -59.71 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' HA ' HD12 ' A' ' 22' ' ' ILE . 48.7 t -71.48 -10.03 59.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.591 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -42.46 63.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 110.655 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 57.87 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 19' ' ' CYS . 27.4 mt -144.37 141.84 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.0 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.39 128.12 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -63.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.615 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 1.5 m-85 -62.65 142.81 57.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 -33.64 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . -142.04 -134.7 3.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.11 156.5 14.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -155.36 -173.59 4.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.718 0.294 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 159.91 26.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.246 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.51 179.35 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER 59.44 32.26 21.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.049 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.98 -16.47 60.84 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.86 11.49 4.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HD3' ' A' ' 7' ' ' PRO . 1.9 m-85 -100.07 0.15 40.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.789 0.294 . . . . 0.0 111.324 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' ' 32' ' ' LYS . 60.7 t -138.15 115.88 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 105.27 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -89.87 176.61 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -175.2 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.941 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.953 0.406 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.34 51.72 0.49 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -176.04 99.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 0.0 110.781 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.58 -49.2 16.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.29 -141.48 8.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' CE1' ' A' ' 35' ' ' PHE . 45.9 Cg_endo -68.57 -46.95 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.635 2.223 . . . . 0.0 112.521 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 45.0 p90 -57.71 -40.42 79.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -153.78 151.88 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -175.27 157.6 2.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -145.63 145.47 30.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.741 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.82 -46.83 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.05 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -51.82 66.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.2 t -75.77 -30.83 59.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.02 -39.47 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.946 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -59.78 -51.18 70.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -59.6 -31.09 69.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -75.29 -30.48 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.3 m -58.99 -31.14 68.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.56 139.98 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 142.68 36.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.33 13.79 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 21.3 m-85 -76.29 -178.31 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 -58.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.25 -169.79 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.19 172.56 27.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -164.1 145.3 8.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.824 0.345 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.0 m -69.99 122.06 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.81 165.71 11.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 60.9 70.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 56.26 36.25 68.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.641 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.49 52.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 7' ' ' PRO . 85.6 m-85 -100.09 -25.55 14.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 37' ' ' CYS . 43.0 t -113.15 159.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.492 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -125.19 138.76 54.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -142.95 154.32 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 79.8 m -116.99 156.1 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.965 0.412 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 19.1 43.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.937 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.59 100.05 10.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 0.0 110.755 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -99.63 29.91 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.9 -150.69 46.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.64 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.97 -20.86 46.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.57 -64.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.958 0.408 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -152.69 148.07 26.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.734 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.67 149.78 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.33 178.52 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.22 -28.44 12.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.3 mtp -99.55 -24.77 14.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.44 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -62.94 1.31 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -59.36 -31.58 69.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 13.5 t60 -68.29 -26.79 65.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -70.44 -51.02 32.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.238 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -49.96 -63.47 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 m -54.19 -26.15 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -29.0 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -97.16 37.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.487 HG21 ' CE2' ' A' ' 25' ' ' TYR . 31.6 mt -137.92 152.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -64.72 128.35 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.173 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -58.02 5.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.761 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CE2' HG21 ' A' ' 22' ' ' ILE . 5.1 m-30 -53.53 169.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 111.294 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 -55.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . -163.3 -88.41 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.24 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.0 -152.15 24.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.634 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -150.44 -177.6 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.98 157.64 18.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.25 158.8 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 62.28 70.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.42 69.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.642 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.14 31.01 77.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.539 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -32.57 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.948 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.2 152.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.195 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 118.32 31.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.9 161.0 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' CG ' ' A' ' 25' ' ' TYR . 74.4 m -138.0 151.55 48.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.775 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.914 0.388 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.04 -28.57 3.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.41 124.18 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.64 77.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.54 160.34 29.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.608 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.427 ' HD2' ' CE3' ' A' ' 8' ' ' TRP . 22.5 Cg_exo -64.57 -40.59 22.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.427 ' CE3' ' HD2' ' A' ' 7' ' ' PRO . 25.0 p90 -62.44 -47.08 85.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.265 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -116.9 125.22 51.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -161.78 175.92 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.89 132.33 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -49.19 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -37.59 77.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -59.68 -53.83 53.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -23.59 59.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.021 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -46.06 80.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.009 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -58.42 -41.16 84.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -64.2 -48.86 74.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.56 -44.36 90.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -58.49 -23.25 57.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.03 38.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 25' ' ' TYR . 53.6 mt -146.59 103.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tttm 50.38 31.22 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.5 -82.55 1.38 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 21.9 m-30 55.41 -177.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.866 0.365 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -128.25 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.62 -143.82 16.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.78 -176.75 47.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -138.75 157.95 45.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 m -82.06 111.2 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.96 151.68 21.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 30.33 12.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.007 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.91 -21.89 34.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.65 -19.11 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.659 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.61 -25.6 27.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 0.0 111.125 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.25 116.54 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 104.85 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.66 173.18 7.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.0 m -131.57 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.92 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.899 0.381 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.57 84.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 109.35 21.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -97.54 36.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.19 -145.58 49.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.39 -8.66 23.81 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 0.0 112.621 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -66.87 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.16 100.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.13 159.36 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.47 150.19 30.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.19 -26.48 13.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 ttm -94.12 -33.29 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -45.74 89.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.0 t -82.03 -36.96 27.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.8 -53.67 50.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -57.92 -30.88 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -65.24 -41.2 94.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.2 m -70.55 -41.06 72.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -26.31 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -91.71 47.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 23' ' ' LYS . 31.8 mt -142.89 156.83 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.077 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 22' ' ' ILE . 3.1 pttp -79.84 106.8 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.57 10.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.546 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 22' ' ' ILE . 6.5 m-85 -128.21 151.46 49.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 -42.42 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.47 -165.34 33.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 165.19 -158.46 31.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.554 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.86 -165.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.324 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 163.33 13.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.039 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.61 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 36' ' ' VAL . 2.8 mtmt 61.12 32.36 19.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.06 -19.28 54.05 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.19 0.91 5.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.093 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -87.15 0.04 55.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 111.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 32' ' ' LYS . 39.5 t -140.62 110.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.25 24.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.705 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HD3' HG12 ' A' ' 36' ' ' VAL . 10.6 mmmm -106.92 178.41 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m -149.71 165.36 32.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.453 ' CE2' ' HA2' ' A' ' 28' ' ' GLY . 35.2 p90 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.6 m-30 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.97 2.04 5.12 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.805 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 100.02 10.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -61.49 -59.48 5.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.48 -169.26 42.39 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.454 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.11 -30.02 68.61 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.518 2.146 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -74.08 -48.61 28.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.041 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.76 143.36 47.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.6 159.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -135.38 134.2 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.622 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.13 -45.42 73.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -10.1 59.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.455 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -59.25 -59.07 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 111.088 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.9 m -59.41 -43.84 92.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.857 0.36 . . . . 0.0 110.784 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -50.83 -27.17 6.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.326 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -59.24 -52.85 63.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -79.91 -33.2 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.4 m -54.82 -34.1 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -31.15 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -62.29 -18.27 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.6 mm -77.26 167.12 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 22' ' ' ILE . 11.0 mmmm -97.29 119.16 35.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.84 18.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.601 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 39' ' ' CYS . 4.1 m-30 -58.63 177.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 31.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.11 -176.6 48.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.23 -135.99 2.27 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -170.78 173.62 5.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 m -70.51 152.96 43.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.75 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.59 35.42 20.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.974 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.12 -1.61 86.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.883 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 18.62 6.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.709 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.21 -27.73 13.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 37' ' ' CYS . 41.9 t -120.04 155.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.434 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . 11.6 m -110.01 132.39 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -108.53 149.66 28.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.049 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 9.8 m -146.11 152.93 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.947 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.68 0.276 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.98 -34.57 2.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 109.49 21.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -84.78 -41.4 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.29 -150.83 22.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.601 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.24 -13.58 36.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.776 2.317 . . . . 0.0 112.787 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -29.28 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.268 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -159.74 148.27 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -176.96 118.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.4 158.42 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -98.77 -30.68 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -30.49 29.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -58.14 -31.93 67.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.7 m -91.42 -35.36 14.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -64.09 -47.3 80.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -56.58 -27.71 58.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.54 -24.75 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.2 t -77.07 -71.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -23.28 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -31.39 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 23' ' ' LYS . 25.7 mt -75.83 158.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.074 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 22' ' ' ILE . 13.6 mttm -88.56 85.0 6.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.93 -28.15 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.21 172.03 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -129.91 -56.27 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.787 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 167.09 40.19 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.267 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.76 -163.27 9.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -160.66 177.06 10.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 32.8 m -96.13 105.67 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . . . -101.15 179.93 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.178 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.527 ' HD2' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 65.0 33.61 9.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.36 81.28 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.975 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 120.44 9.97 7.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -100.09 -33.23 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 111.041 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 32' ' ' LYS . 75.4 t -100.84 154.39 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.439 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.44 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.84 89.84 2.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.069 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.07 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.295 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.9 m -138.43 -174.2 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.775 0.322 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.22 -25.96 20.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.594 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 99.97 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.583 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.77 -48.51 12.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.78 -156.17 24.41 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.51 -36.88 3.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.605 2.203 . . . . 0.0 112.42 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.23 -29.45 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -156.14 140.55 16.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.18 162.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.003 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -118.1 142.85 46.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -100.1 -29.79 12.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -33.21 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -59.48 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -23.06 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.428 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 79.9 t60 -81.6 -40.53 22.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.066 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.74 -58.75 6.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -55.33 -40.83 71.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -58.81 -41.88 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -43.13 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -22.54 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.647 HG21 ' CE2' ' A' ' 25' ' ' TYR . 29.3 mt -63.98 162.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.549 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -43.29 89.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 44.11 27.11 1.02 Allowed Glycine 0 CA--C 1.521 0.424 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.039 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 22' ' ' ILE . 3.4 m-30 -57.09 159.13 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.141 0.471 . . . . 0.0 110.599 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -103.08 36.41 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . 70.85 152.8 1.0 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.16 -169.02 14.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.44 166.32 6.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 130.18 41.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.0 174.15 8.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.089 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.15 35.26 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.66 -20.61 48.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.63 8.0 5.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.045 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 0.23 40.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.8 0.3 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 37' ' ' CYS . 40.2 t -135.99 157.79 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 111.268 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.477 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.95 105.3 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -107.57 152.01 24.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 19.9 m -123.24 -175.97 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.996 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 2.1 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.882 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.42 -34.95 2.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 100.06 10.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -109.63 92.05 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.28 152.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.567 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.87 -26.03 23.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.616 2.211 . . . . 0.0 112.4 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -69.18 -34.06 74.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.026 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.55 123.76 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.74 144.81 20.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.99 148.47 50.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -100.07 -44.92 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mmt -74.83 -35.22 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.57 -34.73 69.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.15 -27.89 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -75.17 -47.76 26.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -65.7 -42.02 91.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.38 -49.7 76.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.092 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.9 m -59.21 -40.85 87.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.28 -28.35 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -10.42 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.474 ' HB ' ' CD1' ' A' ' 25' ' ' TYR . 7.5 mt -89.13 165.08 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.657 0.265 . . . . 0.0 111.025 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.466 ' H ' HG22 ' A' ' 22' ' ' ILE . 12.7 tttp -41.2 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 43.49 73.02 0.27 Allowed Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.079 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CD1' ' HB ' ' A' ' 22' ' ' ILE . 3.2 m-85 -103.71 163.74 12.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 12.3 mttm -122.24 43.51 2.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -171.46 30.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.29 -141.32 3.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.86 -166.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.0 m -101.98 117.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.38 153.58 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.051 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? 58.6 37.53 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.23 -81.55 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.91 26.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.536 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -100.15 -38.45 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 37' ' ' CYS . 13.0 t -114.57 159.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.479 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -137.86 112.9 9.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.771 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -114.35 154.57 27.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -170.35 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.721 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CZ ' ' O ' ' A' ' 26' ' ' LYS . 6.1 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.848 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.99 -26.5 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -99.96 99.98 10.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.82 0.343 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -89.8 -38.31 13.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 35' ' ' PHE . . . -165.29 169.63 39.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.522 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD2' ' CZ3' ' A' ' 8' ' ' TRP . 60.1 Cg_exo -51.66 -33.68 50.16 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.423 ' CZ3' ' HD2' ' A' ' 7' ' ' PRO . 45.9 p90 -87.9 -33.75 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.17 111.02 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -157.58 173.73 16.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.024 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 159.53 38.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -100.21 -38.8 8.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.9 mmt -99.67 -29.57 12.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.376 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.41 -34.57 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.03 -29.33 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 33.5 t60 -73.74 -46.32 46.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.975 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.36 -45.93 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -63.25 -47.76 81.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.18 -30.15 71.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -32.57 68.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -28.26 65.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.078 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' LYS . 19.7 mt -89.33 157.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -100.29 147.48 25.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.69 -35.61 4.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.575 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -102.21 165.31 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -119.05 31.06 6.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . 138.71 -159.1 25.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.67 167.84 39.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.7 161.64 13.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 82.2 m -86.34 109.91 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . . . -89.9 -178.68 5.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.973 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.6 mttp 49.76 69.1 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.44 54.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.173 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 74.31 16.1 79.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 1.8 t80 -100.29 0.21 39.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' ALA . 87.7 t -142.02 114.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.703 0.287 . . . . 0.0 111.446 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.82 138.84 31.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.629 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -145.66 178.46 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -118.22 120.86 38.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.875 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.89 28.65 11.84 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 108.15 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.747 0.308 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 8' ' ' TRP . 18.6 m-80 -124.46 39.86 3.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.23 -149.91 38.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.57 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -72.89 -41.8 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.673 2.249 . . . . 0.0 112.529 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -57.83 -28.62 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -159.46 136.51 9.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.909 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -178.15 138.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.03 161.39 26.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -100.09 -33.66 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.228 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.13 -26.61 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.265 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -58.71 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.021 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.41 -30.12 71.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.454 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 13.4 t60 -57.7 -44.4 85.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.83 -45.6 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.07 -59.71 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.48 ' HA ' HD12 ' A' ' 22' ' ' ILE . 48.7 t -71.48 -10.03 59.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.591 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -42.46 63.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 110.655 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 57.87 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 19' ' ' CYS . 27.4 mt -144.37 141.84 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.0 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.39 128.12 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -63.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.615 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 1.5 m-85 -62.65 142.81 57.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 -33.64 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . -142.04 -134.7 3.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.11 156.5 14.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -155.36 -173.59 4.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.718 0.294 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 159.91 26.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.246 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.51 179.35 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER 59.44 32.26 21.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.049 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.98 -16.47 60.84 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.86 11.49 4.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HD3' ' A' ' 7' ' ' PRO . 1.9 m-85 -100.07 0.15 40.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.789 0.294 . . . . 0.0 111.324 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' ' 32' ' ' LYS . 60.7 t -138.15 115.88 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 105.27 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -89.87 176.61 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -175.2 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.941 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.598 ' H3 ' ' HB3' ' A' ' 18' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.544 -0.223 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 61.29 56.39 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.953 0.406 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.34 51.72 0.49 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.482 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -176.04 99.93 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.811 0.339 . . . . 0.0 110.781 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.58 -49.2 16.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.29 -141.48 8.26 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.464 ' HD3' ' CE1' ' A' ' 35' ' ' PHE . 45.9 Cg_endo -68.57 -46.95 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.635 2.223 . . . . 0.0 112.521 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.42 ' CD1' ' HB2' ' A' ' 9' ' ' ASP . 45.0 p90 -57.71 -40.42 79.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.075 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' HB2' ' CD1' ' A' ' 8' ' ' TRP . 1.6 m-20 -153.78 151.88 30.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.854 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -175.27 157.6 2.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.038 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -145.63 145.47 30.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.741 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -99.82 -46.83 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.002 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -32.24 73.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.05 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -51.82 66.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 2.2 t -75.77 -30.83 59.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -68.02 -39.47 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.946 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.96 -40.79 95.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.598 ' HB3' ' H3 ' ' A' ' 1' ' ' GLY . 47.1 t-80 -59.78 -51.18 70.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 57.0 m -59.6 -31.09 69.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.96 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -75.29 -30.48 60.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.976 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.3 m -58.99 -31.14 68.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.2 mt -85.56 139.98 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 142.68 36.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.55 -28.33 13.79 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.51 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.441 ' CD2' ' HB3' ' A' ' 39' ' ' CYS . 21.3 m-85 -76.29 -178.31 4.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.352 . . . . 0.0 110.885 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.31 -58.22 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.945 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.25 -169.79 18.06 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.514 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -147.19 172.56 27.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -164.1 145.3 8.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.824 0.345 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.0 m -69.99 122.06 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -108.81 165.71 11.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 60.9 70.05 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.037 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 35' ' ' PHE . . . 56.26 36.25 68.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.641 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.97 21.49 52.71 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.464 ' CE1' ' HD3' ' A' ' 7' ' ' PRO . 85.6 m-85 -100.09 -25.55 14.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.94 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 37' ' ' CYS . 43.0 t -113.15 159.59 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.492 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -125.19 138.76 54.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mtmm -142.95 154.32 43.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 79.8 m -116.99 156.1 28.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 14.4 p90 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.938 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.561 -0.216 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 59.5 60.3 2.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.965 0.412 . . . . 0.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.95 19.1 43.98 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.937 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.59 100.05 10.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.844 0.354 . . . . 0.0 110.755 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -99.63 29.91 3.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.991 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.9 -150.69 46.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.64 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.97 -20.86 46.96 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.57 -64.83 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.958 0.408 . . . . 0.0 110.839 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -152.69 148.07 26.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.734 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -171.67 149.78 2.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.33 178.52 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.78 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -100.22 -28.44 12.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.3 mtp -99.55 -24.77 14.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.44 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.54 -62.94 1.31 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.761 0.315 . . . . 0.0 111.127 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -59.36 -31.58 69.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.416 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 13.5 t60 -68.29 -26.79 65.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -70.44 -51.02 32.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.238 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -49.96 -63.47 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.163 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.8 m -54.19 -26.15 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.7 -29.0 67.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.872 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -97.16 37.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.038 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.487 HG21 ' CE2' ' A' ' 25' ' ' TYR . 31.6 mt -137.92 152.87 26.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.11 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -64.72 128.35 35.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.173 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.08 -58.02 5.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.761 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.487 ' CE2' HG21 ' A' ' 22' ' ' ILE . 5.1 m-30 -53.53 169.9 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 111.294 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 -55.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . -163.3 -88.41 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.24 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.0 -152.15 24.38 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.634 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -150.44 -177.6 6.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.814 0.34 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 81.2 m -87.98 157.64 18.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.826 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -130.25 158.8 38.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp 62.28 70.13 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.039 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.58 34.42 69.56 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.642 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.14 31.01 77.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.539 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.0 -32.57 10.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.869 0.366 . . . . 0.0 110.948 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -107.2 152.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.195 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -118.2 118.32 31.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -102.9 161.0 14.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.436 ' HB3' ' CG ' ' A' ' 25' ' ' TYR . 74.4 m -138.0 151.55 48.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.775 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.883 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 60.6 30.82 20.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.914 0.388 . . . . 0.0 110.958 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.04 -28.57 3.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.41 124.18 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.765 0.317 . . . . 0.0 110.877 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -126.64 77.98 1.75 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.95 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.54 160.34 29.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.608 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.427 ' HD2' ' CE3' ' A' ' 8' ' ' TRP . 22.5 Cg_exo -64.57 -40.59 22.79 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.706 2.271 . . . . 0.0 112.291 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.427 ' CE3' ' HD2' ' A' ' 7' ' ' PRO . 25.0 p90 -62.44 -47.08 85.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.265 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -116.9 125.22 51.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -161.78 175.92 11.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.12 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.89 132.33 12.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.736 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -80.31 -49.19 11.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.152 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.07 -37.59 77.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.049 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -59.68 -53.83 53.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.991 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -23.59 59.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.021 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.52 -46.06 80.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.009 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 -58.42 -41.16 84.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -64.2 -48.86 74.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.3 m -64.56 -44.36 90.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.941 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -58.49 -23.25 57.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.175 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.03 38.2 1.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.033 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' CD2' ' A' ' 25' ' ' TYR . 53.6 mt -146.59 103.64 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.6 tttm 50.38 31.22 5.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.5 -82.55 1.38 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.437 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 21.9 m-30 55.41 -177.57 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.866 0.365 . . . . 0.0 110.948 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.6 mtpm? -128.25 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 109.62 -143.82 16.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.477 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.78 -176.75 47.56 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -138.75 157.95 45.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.778 0.323 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.9 m -82.06 111.2 17.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.822 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.96 151.68 21.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.203 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 30.33 12.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.007 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.91 -21.89 34.3 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.761 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 147.65 -19.11 1.47 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.659 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -54.61 -25.6 27.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.716 0.293 . . . . 0.0 111.125 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 t -134.25 116.54 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.14 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.67 104.85 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.822 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -95.66 173.18 7.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.985 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.0 m -131.57 -174.92 3.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.716 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.92 179.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 60.91 37.23 18.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.381 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.3 -5.57 84.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.8 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.0 109.35 21.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.753 0.311 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -97.54 36.58 1.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.19 -145.58 49.75 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.411 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.39 -8.66 23.81 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.558 2.172 . . . . 0.0 112.621 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -66.87 0.5 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -160.16 100.1 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.893 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.13 159.36 15.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.982 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.47 150.19 30.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.878 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -100.19 -26.48 13.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.4 ttm -94.12 -33.29 13.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -45.74 89.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.0 t -82.03 -36.96 27.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -62.8 -53.67 50.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -57.92 -30.88 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.945 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -65.24 -41.2 94.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.2 m -70.55 -41.06 72.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.83 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -26.31 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.1 m -91.71 47.7 1.39 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.065 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG22 ' N ' ' A' ' 23' ' ' LYS . 31.8 mt -142.89 156.83 17.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.077 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' N ' HG22 ' A' ' 22' ' ' ILE . 3.1 pttp -79.84 106.8 12.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.97 29.57 10.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.546 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD1' ' CG2' ' A' ' 22' ' ' ILE . 6.5 m-85 -128.21 151.46 49.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.85 -42.42 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.47 -165.34 33.99 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.519 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' HA2' ' CE2' ' A' ' 40' ' ' TYR . . . 165.19 -158.46 31.31 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.554 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.86 -165.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.779 0.324 . . . . 0.0 110.839 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 163.33 13.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.039 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.61 168.77 18.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.066 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.552 ' HE3' HG21 ' A' ' 36' ' ' VAL . 2.8 mtmt 61.12 32.36 19.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 94.06 -19.28 54.05 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.734 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 130.19 0.91 5.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.093 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -87.15 0.04 55.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.808 0.304 . . . . 0.0 111.442 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 32' ' ' LYS . 39.5 t -140.62 110.18 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.852 0.358 . . . . 0.0 111.269 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.25 24.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.705 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HD3' HG12 ' A' ' 36' ' ' VAL . 10.6 mmmm -106.92 178.41 4.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.151 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 90.9 m -149.71 165.36 32.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.737 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.453 ' CE2' ' HA2' ' A' ' 28' ' ' GLY . 35.2 p90 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 15' ' ' CYS . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.6 m-30 71.85 38.54 0.93 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.867 0.365 . . . . 0.0 111.18 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.97 2.04 5.12 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.805 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.96 100.02 10.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.831 0.348 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -61.49 -59.48 5.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.48 -169.26 42.39 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.454 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.11 -30.02 68.61 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.518 2.146 . . . . 0.0 112.357 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 45.4 p90 -74.08 -48.61 28.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.041 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -134.76 143.36 47.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.905 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.6 159.04 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 14' ' ' GLN . 0.1 OUTLIER -135.38 134.2 39.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.622 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -68.13 -45.42 73.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.21 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -75.4 -10.1 59.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.455 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -59.25 -59.07 6.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 111.088 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 1' ' ' GLY . 22.9 m -59.41 -43.84 92.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.857 0.36 . . . . 0.0 110.784 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -50.83 -27.17 6.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.326 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -59.24 -52.85 63.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -79.91 -33.2 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 75.4 m -54.82 -34.1 62.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -31.15 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.841 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.5 t -62.29 -18.27 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.268 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' N ' HD13 ' A' ' 22' ' ' ILE . 1.6 mm -77.26 167.12 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 22' ' ' ILE . 11.0 mmmm -97.29 119.16 35.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 95.69 -26.84 18.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.601 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 39' ' ' CYS . 4.1 m-30 -58.63 177.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.782 0.325 . . . . 0.0 110.993 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.08 31.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.936 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.11 -176.6 48.87 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.456 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -176.23 -135.99 2.27 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -170.78 173.62 5.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 17.0 m -70.51 152.96 43.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.75 171.53 13.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.102 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.59 35.42 20.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.974 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.12 -1.61 86.44 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.883 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.56 18.62 6.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.709 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.21 -27.73 13.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.744 0.307 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 37' ' ' CYS . 41.9 t -120.04 155.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.892 0.377 . . . . 0.0 111.434 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.446 ' N ' HG12 ' A' ' 36' ' ' VAL . 11.6 m -110.01 132.39 54.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.517 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -108.53 149.66 28.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.911 0.386 . . . . 0.0 111.049 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.438 ' HB2' ' CE2' ' A' ' 25' ' ' TYR . 9.8 m -146.11 152.93 40.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.825 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.3 p90 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.947 179.892 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.523 -0.231 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 58.41 28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.68 0.276 . . . . 0.0 111.003 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.98 -34.57 2.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.518 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.03 109.49 21.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.852 0.358 . . . . 0.0 110.837 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -84.78 -41.4 16.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.961 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 144.29 -150.83 22.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.601 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.24 -13.58 36.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.776 2.317 . . . . 0.0 112.787 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -94.63 -29.28 14.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.664 0.268 . . . . 0.0 111.222 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -159.74 148.27 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -176.96 118.37 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -111.4 158.42 19.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.746 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -98.77 -30.68 12.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.049 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -30.49 29.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.133 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -58.14 -31.93 67.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.7 m -91.42 -35.36 14.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.744 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -64.09 -47.3 80.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -56.58 -27.71 58.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.54 -24.75 31.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.142 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.2 t -77.07 -71.18 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.178 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.99 -23.28 18.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.65 -31.39 68.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.983 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 23' ' ' LYS . 25.7 mt -75.83 158.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.074 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' N ' HG22 ' A' ' 22' ' ' ILE . 13.6 mttm -88.56 85.0 6.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 143.93 -28.15 2.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -81.21 172.03 14.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.828 0.347 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -129.91 -56.27 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.787 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 167.09 40.19 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.267 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.76 -163.27 9.64 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.604 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.522 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -160.66 177.06 10.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.866 0.365 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 32.8 m -96.13 105.67 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 29' ' ' TYR . . . -101.15 179.93 4.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.178 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.527 ' HD2' HG23 ' A' ' 36' ' ' VAL . 0.4 OUTLIER 65.0 33.61 9.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.056 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.2 -4.36 81.28 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.975 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 120.44 9.97 7.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.019 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -100.09 -33.23 10.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.781 0.324 . . . . 0.0 111.041 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 32' ' ' LYS . 75.4 t -100.84 154.39 4.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.439 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.44 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.84 89.84 2.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.069 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.41 179.07 5.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.295 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.9 m -138.43 -174.2 3.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 p90 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.87 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.093 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 60.34 31.33 20.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.775 0.322 . . . . 0.0 110.81 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.22 -25.96 20.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.594 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 99.97 10.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.812 0.339 . . . . 0.0 110.583 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.77 -48.51 12.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.014 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.78 -156.17 24.41 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.52 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.51 -36.88 3.52 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.605 2.203 . . . . 0.0 112.42 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.23 -29.45 65.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.055 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -156.14 140.55 16.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -177.18 162.17 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.003 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -118.1 142.85 46.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -100.1 -29.79 12.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.11 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.13 -33.21 17.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -59.48 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -23.06 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.177 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.428 ' CE1' ' HA3' ' A' ' 27' ' ' GLY . 79.9 t60 -81.6 -40.53 22.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.066 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -61.74 -58.75 6.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -55.33 -40.83 71.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.066 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 34.6 t -58.81 -41.88 87.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.027 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.87 -43.13 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -22.54 41.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.197 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.647 HG21 ' CE2' ' A' ' 25' ' ' TYR . 29.3 mt -63.98 162.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.977 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.549 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -43.29 89.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 44.11 27.11 1.02 Allowed Glycine 0 CA--C 1.521 0.424 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.039 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.647 ' CE2' HG21 ' A' ' 22' ' ' ILE . 3.4 m-30 -57.09 159.13 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.141 0.471 . . . . 0.0 110.599 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -103.08 36.41 2.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.061 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 16' ' ' HIS . . . 70.85 152.8 1.0 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.356 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.16 -169.02 14.54 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.562 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.44 166.32 6.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.06 130.18 41.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.963 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.0 174.15 8.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.089 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.15 35.26 21.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.016 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.66 -20.61 48.89 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.63 8.0 5.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.045 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.11 0.23 40.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.8 0.3 . . . . 0.0 111.387 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 37' ' ' CYS . 40.2 t -135.99 157.79 38.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.805 0.336 . . . . 0.0 111.268 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.477 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -128.95 105.3 8.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -107.57 152.01 24.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 19.9 m -123.24 -175.97 3.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.996 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 40' ' ' TYR . 2.1 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.268 -0.873 . . . . 0.0 110.882 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 59.68 31.64 21.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.42 -34.95 2.23 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.12 100.06 10.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -109.63 92.05 3.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.979 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 62.28 152.45 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.567 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.87 -26.03 23.2 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.616 2.211 . . . . 0.0 112.4 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -69.18 -34.06 74.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.026 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.55 123.76 27.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.74 144.81 20.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.99 148.47 50.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.839 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -100.07 -44.92 5.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.084 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mmt -74.83 -35.22 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.075 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.57 -34.73 69.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.949 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 m -89.15 -27.89 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -75.17 -47.76 26.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -65.7 -42.02 91.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -58.38 -49.7 76.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.092 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.9 m -59.21 -40.85 87.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.063 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.28 -28.35 18.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.288 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.11 -10.42 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.402 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.474 ' HB ' ' CD1' ' A' ' 25' ' ' TYR . 7.5 mt -89.13 165.08 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.657 0.265 . . . . 0.0 111.025 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.466 ' H ' HG22 ' A' ' 22' ' ' ILE . 12.7 tttp -41.2 88.81 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' ILE . . . 43.49 73.02 0.27 Allowed Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.954 -0.566 . . . . 0.0 114.079 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' CD1' ' HB ' ' A' ' 22' ' ' ILE . 3.2 m-85 -103.71 163.74 12.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.808 0.337 . . . . 0.0 110.873 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' O ' ' CZ ' ' A' ' 40' ' ' TYR . 12.3 mttm -122.24 43.51 2.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -171.46 30.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.513 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -168.29 -141.32 3.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.57 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.86 -166.03 1.51 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.876 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 92.0 m -101.98 117.16 34.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.38 153.58 20.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.051 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? 58.6 37.53 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.23 -81.55 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.453 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.91 26.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.536 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -100.15 -38.45 8.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.774 0.321 . . . . 0.0 111.058 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 37' ' ' CYS . 13.0 t -114.57 159.72 14.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.271 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.479 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -137.86 112.9 9.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.771 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 mttt -114.35 154.57 27.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -170.35 2.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.721 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CZ ' ' O ' ' A' ' 26' ' ' LYS . 6.1 p90 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.176 -0.916 . . . . 0.0 110.848 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 59.06 26.14 14.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.783 0.325 . . . . 0.0 111.061 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 112.99 -26.5 10.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -99.96 99.98 10.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.82 0.343 . . . . 0.0 110.829 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -89.8 -38.31 13.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' HA2' ' CD1' ' A' ' 35' ' ' PHE . . . -165.29 169.63 39.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.522 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HD2' ' CZ3' ' A' ' 8' ' ' TRP . 60.1 Cg_exo -51.66 -33.68 50.16 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.595 2.197 . . . . 0.0 112.383 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.423 ' CZ3' ' HD2' ' A' ' 7' ' ' PRO . 45.9 p90 -87.9 -33.75 18.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -113.17 111.02 21.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -157.58 173.73 16.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.024 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.64 159.53 38.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.719 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -100.21 -38.8 8.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 12.9 mmt -99.67 -29.57 12.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.376 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.41 -34.57 66.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.03 -29.33 15.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 33.5 t60 -73.74 -46.32 46.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.975 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -57.36 -45.93 83.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.102 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -63.25 -47.76 81.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.946 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.18 -30.15 71.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.6 -32.57 68.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.68 -28.26 65.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.078 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 23' ' ' LYS . 19.7 mt -89.33 157.39 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.064 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' N ' HG22 ' A' ' 22' ' ' ILE . 0.3 OUTLIER -100.29 147.48 25.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.69 -35.61 4.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.575 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 39' ' ' CYS . 1.0 OUTLIER -102.21 165.31 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mtmp? -119.05 31.06 6.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.832 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . 138.71 -159.1 25.32 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.53 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.67 167.84 39.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.7 161.64 13.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 111.051 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 82.2 m -86.34 109.91 19.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.499 ' HB2' ' HD2' ' A' ' 38' ' ' LYS . . . -89.9 -178.68 5.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.973 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.6 mttp 49.76 69.1 0.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.84 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.92 22.44 54.7 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.173 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 30' ' ' CYS . . . 74.31 16.1 79.95 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.666 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.423 ' CD1' ' HA2' ' A' ' 6' ' ' GLY . 1.8 t80 -100.29 0.21 39.72 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' ALA . 87.7 t -142.02 114.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.703 0.287 . . . . 0.0 111.446 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.82 138.84 31.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.629 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -145.66 178.46 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -118.22 120.86 38.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.2 p90 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.875 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 59.97 59.97 2.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.96 0.409 . . . . 0.0 110.857 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.89 28.65 11.84 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.48 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.35 108.15 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.747 0.308 . . . . 0.0 110.754 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.413 ' HB3' ' CH2' ' A' ' 8' ' ' TRP . 18.6 m-80 -124.46 39.86 3.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.969 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 76.23 -149.91 38.06 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.57 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 35' ' ' PHE . 60.8 Cg_endo -72.89 -41.8 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.673 2.249 . . . . 0.0 112.529 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.413 ' CH2' ' HB3' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -57.83 -28.62 64.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.831 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' OD1' ' CD1' ' A' ' 8' ' ' TRP . 0.3 OUTLIER -159.46 136.51 9.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.909 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -178.15 138.61 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.03 161.39 26.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -100.09 -33.66 10.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.228 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.13 -26.61 13.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.265 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.49 -58.71 7.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.021 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.41 -30.12 71.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.857 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.454 ' CE1' ' HA2' ' A' ' 27' ' ' GLY . 13.4 t60 -57.7 -44.4 85.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.917 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -53.83 -45.6 70.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.217 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -58.07 -59.71 4.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.949 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.48 ' HA ' HD12 ' A' ' 22' ' ' ILE . 48.7 t -71.48 -10.03 59.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.591 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -42.46 63.55 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.803 0.335 . . . . 0.0 110.655 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.42 57.87 4.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.065 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 19' ' ' CYS . 27.4 mt -144.37 141.84 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.0 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.39 128.12 35.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.985 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.72 -63.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.615 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.41 ' N ' ' CD1' ' A' ' 25' ' ' TYR . 1.5 m-85 -62.65 142.81 57.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.829 0.347 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.36 -33.64 7.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.644 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' HA2' ' CE1' ' A' ' 16' ' ' HIS . . . -142.04 -134.7 3.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.11 156.5 14.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.59 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -155.36 -173.59 4.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.718 0.294 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 159.91 26.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.246 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.51 179.35 6.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.018 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.434 ' HE2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER 59.44 32.26 21.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.049 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.98 -16.47 60.84 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.86 11.49 4.85 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.972 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HD3' ' A' ' 7' ' ' PRO . 1.9 m-85 -100.07 0.15 40.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.789 0.294 . . . . 0.0 111.324 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.434 HG21 ' HE2' ' A' ' 32' ' ' LYS . 60.7 t -138.15 115.88 12.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.804 0.335 . . . . 0.0 111.233 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.55 105.27 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.736 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -89.87 176.61 6.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.36 -175.2 3.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.805 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.941 -179.99 . . . . . . . . 0 0 . 1 stop_ save_